Similar biological medicinal products containing interferon beta

Current effective version

PDF iconAdopted guideline

Reference numberEMA/CHMP/BMWP/652000/2010
Effective from01/09/2013
KeywordsInterferon beta, similar biological medicinal product, biosimilar, comparability, non-clinical studies, clinical studies
DescriptionThis document lays down the non-clinical and clinical requirements for interferon beta (IFN-β) containing medicinal products claiming to be similar to another interferon beta already marketed.

Document history

First version

Current version

PDF iconAdopted guideline

PDF iconOverview of comments

PDF iconDraft guideline

PDF iconConcept paper

In operation: 01/09/2013–present

Published: 06/03/2013

Published: 19/01/2012

Published: 06/04/2010

Related content

How useful was this page?

Add your rating